Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e.13th August, 2024 have 1. Approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2024 and Limited Review Report issued by the Statutory Auditors of the Company attached herewith. 2. Approved the appointment of Ms. Dhwani Solanki (DIN- 10299290) as an Additional Director in the category of Non- executive Independent Director of the Company for term of 5 years. 3.Acceptance of the Resignation received from Mr. Niranjan Agarwal [ DIN: 06503361], non-executive independent Director of the Company, due to his personal reasons, with effect from close of business hours on 13th August, 2024. 4. Considered and approved the amendment in the Notice for convening the 31st Annual General Meeting of the Company.